Guide to Combating Coronavirus Drug Development Challenges

The Coronavirus Ripple Effect: Analyzing the Challenges Impacting New Drug Development

The Coronavirus Ripple Effect: Analyzing the Challenges Impacting New Drug Development

As China accounts for roughly 40% of the global active pharmaceutical ingredients production, the outbreak of the novel coronavirus could potentially disrupt the drug supply and business of branded and generic drug manufacturers. Since the emergence of COVID-19, drug manufacturers are racing to speed the development of diagnostics for detecting the infectious agent and developing […]

READ MORE >>

Close
Infiti Logo

Hello there!

Contact us to know more about our cost-effective custom market research offerings to support efficient market penetration, new product launch, and devise strategies to monitor and outperform your competitors.

Cookie Policy

The Site uses cookies to record users' preferences in relation to the functionality of accessibility. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice